PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis.
Chia-Lin ChouTzu-Ju ChenCheng-Yi LinSung-Wei LeeShih-Chang WangShou-Sheng ChuChing-Chieh YangPublished in: OncoTargets and therapy (2020)
Determination of PCSK1 overexpression may be useful for identifying rectal cancer patients at risk for a poor response and worse survival after CCRT.
Keyphrases
- rectal cancer
- locally advanced
- end stage renal disease
- cell proliferation
- chronic kidney disease
- ejection fraction
- newly diagnosed
- transcription factor
- squamous cell carcinoma
- patients undergoing
- peritoneal dialysis
- prognostic factors
- patient reported outcomes
- high resolution
- patient reported
- low density lipoprotein
- mass spectrometry